reSee.it - Related Video Feed

The brain has significant control over bodily functions, even in extreme situations. Clinical hypnosis, referred to as transformation trance by Dr. David Spiegel, is a therapeutic protocol that enhances control rather than diminishing it. It can improve sleep, performance, and serve as a tool against addiction, trauma, anxiety, and chronic pain. Dr. Spiegel, a leading expert in hypnosis, discusses the neurobiology of hypnosis and its various applications. He emphasizes that hypnosis is a naturally occurring state of focused attention with reduced peripheral awareness, differing from the misconceptions associated with stage hypnosis. Dr. Spiegel shares his background, including a misunderstanding with a different David Spiegel during a high-profile trial, and clarifies the distinction between clinical and stage hypnosis. He explains that hypnosis has historical roots dating back 250 years to Franz Anton Mesmer, who initially theorized about magnetic fields affecting health. Although Mesmer's theories were flawed, his work laid the groundwork for understanding hypnosis as a therapeutic tool. The conversation explores the mind-body connection in hypnosis, highlighting how individuals can dissociate and focus intensely, which can lead to cognitive flexibility and learning. Dr. Spiegel discusses hypnotizability, suggesting it may have genetic components and is influenced by early life experiences. He introduces the Spiegel test to gauge hypnotizability and explains the importance of eye movement in this context. The discussion shifts to self-hypnosis and the Reverie app developed by Dr. Spiegel's team, which offers interactive digital hypnosis for various issues, including stress and smoking cessation. He emphasizes the significance of language in hypnosis, aiming for clarity and positivity to enhance receptivity. Dr. Spiegel also reflects on his work with cancer patients, noting that facing mortality can lead to personal growth and improved mental health. He shares insights on the importance of acceptance in reducing anxiety and the potential benefits of psychedelics in enhancing receptivity to hypnosis. In conclusion, Dr. Spiegel encourages individuals to explore hypnosis as a low-risk method for addressing personal challenges, suggesting that it can provide new perspectives on problems and improve overall well-being. He advocates for finding trained professionals in clinical hypnosis and emphasizes the potential of self-hypnosis through tools like the Reverie app.

Whitney Webb and Johnny Vedmore discuss how elite institutions that steered COVID-19 policies are moving to shape a post-COVID world, focusing on Welcome Leap and the Trinity Challenge, and tracing their ties to the Wellcome Trust, the Gates Foundation, DARPA, and Silicon Valley. They note Welcome Leap’s deep links to the Wellcome Trust, which was involved with the Oxford AstraZeneca vaccine, and highlight a framework in which philanthropy blends with biotech and for‑profit entities. They quote a Sunday Times profile describing Wellcome as a vehicle where “what Henry Welcom set out was a double edged scheme to run a business and a charity together. The flagship would be a philanthropic body, now the Wellcome Trust, enjoying the image and tax benefits of magnanimous public spirited generosity. But behind this would operate, industrial organizations and, straight up and down for profit corporations.” They ask who holds more sway over public policy—Bill Gates or the Wellcome Trust?—noting overlap between Gates Foundation and Wellcome Trust in the developing world. They discuss Welcome Leap’s leadership: Regina Dugan, who began at DARPA in 1996, leading a program that won awards for identifying land mines, then headed a counterism task force, and later created a defense‑focused tech firm Red X Defense that contracted with the military. Dugan “greenlighted DARPA's investment in mRNA vaccine technology” and, after leaving DARPA, was recruited by Google to lead Building 8, with projects including “digital tattoo” and “digital authentication pill,” and a focus on neural wearables and transhumanist aims. Dugan’s association with the Clinton Global Initiative and Bilderberg, and her role in Google’s DARPA‑like efforts, are cited as part of a broader transhumanist trajectory. Ken Gabriel, COO of Welcome Leap, is described as a DARPA veteran who led MEMS research, worked with both the FBI and CIA, and later joined Draper Labs before becoming involved with the Wellcome Trust; he sits on the Galvani Bioelectronics board, linking GlaxoSmithKline, Google, and Verily. Jay Flatley, Illumina’s longtime chief, is highlighted as a genomics power broker tied to the World Economic Forum and a push to gene‑tested populations from birth to grave. The four Welcome Leap programs are introduced. HOPE stands for human organs, physiology, and engineering, with aims to grow and translate organ systems that “will have a functional immune system,” potentially replacing animal trials and advancing bioengineering for transplantable organs and synthetic hybrid organs. The second program, the “first thousand days,” targets infants from three months to three years, outlining “wearables, constant twenty four seven surveillance of children,” including respiratory rate, heart rate, eye tracking, and ambient data to build an “in silico” AI model of a child’s brain, with the goal of having “eighty percent of children” matched to the synthetic model within ten years. The third program, Delta Tissue, is described as precision medicine to map cells and tissues for cancer prediction and prevention, potentially enabling AI‑driven interventions. The fourth, Multi Channel Psych, aims to study “anhedonia” and to develop brain stimulation interventions to shape behavior, including mood quantification, and to create scalable measurement tools via wearables that monitor mood, sleep, social interactions, and reward processing. They turn to the Trinity Challenge, chaired by Dame Sally Davies, with founding members including the University of Hong Kong, Cambridge, Northeastern, Imperial College London, and corporations such as Microsoft, Facebook, Google, GlaxoSmithKline, and McKinsey, plus the Gates Foundation, Tencent, Aviva, and a Global Virome Project linked to EcoHealth Alliance and USAID. The grand prize went to POD (participatory one health disease detection) led by Open Dream in Thailand, with Matt Parker connected to Salesforce; Jane Sexbot (a child sex‑education chatbot) was another project. Founding members include the Skull Global Threats Fund, tied to Jeffrey Skoll, and its leadership connected to Google, Salesforce, the WEF, and CFR, underscoring the convergence of tech, pharma, and policy elites in shaping surveillance, data analytics, and predictive health, framed as preventing pandemics but described as moving toward surveillance, eugenics, and transhumanism. They warn that post‑COVID agendas are being advanced behind distractions about variants, urging pushback and accountability.

In this a16z podcast episode, hosts Kyle Russell and Saku Hatsanai discuss nootropics, cognitive enhancers that improve brain performance, with Nootrobox co-founders Jeffrey Wu and Michael Brandt. They explore how nootropics differ from coffee, emphasizing benefits like improved focus, relaxation, and memory without the jitters associated with caffeine. Wu explains that nootropics work through increasing neurotransmitter levels, enhancing blood flow, and providing neuroprotective effects. The conversation highlights the lack of pharmaceutical endorsement for these supplements due to their generic nature, which prevents patenting. The Nootrobox team focuses on scientifically-backed compounds, aiming to provide transparency in the supplement industry, contrasting with proprietary blends often seen elsewhere. They draw parallels between the nootropic community and early computing enthusiasts, suggesting that cognitive enhancement could become mainstream. The discussion also touches on the potential for personalized supplements based on individual data, emphasizing the democratization of cognitive enhancement and its societal benefits. Ultimately, they envision a future where everyone can access tools to optimize their cognitive performance.

In this episode of Mind Pump, hosts Sal Di Stefano, Adam Schafer, and Justin Andrews discuss their experiences with Brain.fm, a music platform designed to enhance focus and sleep. Initially skeptical, Adam found that Brain.fm significantly improved his sleep quality, prompting the entire team to try it. They describe how the music helps settle their minds, allowing for increased productivity and focus during tasks. The episode features an interview with Dan Clark, the CEO of Brain.fm, who shares insights about the company's impressive 300% growth and its focus on scientific validation. Brain.fm employs various testing methods, including fMRI and EEG, to study the effects of their music on brain activity. They are developing new features, such as personalized playlists based on user preferences and tasks, which aim to enhance user experience. Clark highlights the community aspect of Brain.fm, with users actively providing feedback and suggestions. The platform is being explored for potential applications in medical settings, particularly for conditions like ADHD and anxiety. Future plans include partnerships with wearable tech and the introduction of guided meditation experiences. The conversation emphasizes the transformative potential of Brain.fm in helping users achieve better focus and relaxation.

David Spiegel, a psychiatrist and expert in hypnosis, shares insights about the history and applications of hypnosis, particularly in treating trauma and pain management. He recounts how his father, also a psychiatrist, learned hypnosis during World War II to help soldiers cope with combat stress and pain. Spiegel emphasizes that hypnosis involves heightened focus and cognitive flexibility, allowing individuals to reinterpret their experiences and manage symptoms effectively. He distinguishes hypnosis from meditation and flow states, noting that hypnosis is goal-oriented and involves suggestibility, while meditation promotes open presence. Spiegel explains that highly hypnotizable individuals can quickly absorb new information and change their perspectives, which is beneficial in therapeutic contexts. Spiegel discusses the neurobiological mechanisms behind hypnosis, highlighting its ability to modulate pain perception by altering brain activity. He notes that hypnosis can significantly reduce pain and stress, often more effectively than medications. He shares anecdotes of patients who experienced remarkable transformations through hypnosis, including a young girl with asthma and a veteran struggling with PTSD. He also addresses the potential of hypnosis in addiction treatment, stating that it can help individuals focus on positive behaviors rather than urges. Spiegel advocates for hypnosis as a first-line treatment option, given its favorable risk profile compared to pharmaceuticals. Spiegel introduces his app, Ry, designed to help users practice self-hypnosis for various issues, including pain and anxiety. He encourages people to explore hypnosis as a valuable tool for self-improvement and healing, emphasizing its underutilization in modern medicine. He concludes by recommending professional hypnosis societies and resources for those interested in learning more about hypnosis and its applications.

Teaching people to control pain, stress, anxiety, insomnia, and habits through hypnosis is a superior treatment method. Hypnosis, the oldest Western psychotherapy, involves focused attention and cognitive flexibility, allowing individuals to dissociate from distractions and gain control over their mind and body. In clinical settings, hypnosis can significantly reduce pain by altering the brain's interpretation of pain signals. For example, a pregnant woman experienced a reduction in back pain from a seven to a three out of ten by imagining warmth and comfort. Dr. David Spiegel developed the interactive hypnosis app, Reverie, to help individuals manage pain, stress, and habits independently. Hypnotizability varies among individuals, with about two-thirds of adults being somewhat hypnotizable. Techniques can be tailored based on a person's level of suggestibility. Hypnosis has proven effective for pain management, anxiety, and even mental health issues like PTSD, providing a safe alternative to medications, especially amid the opioid crisis. Despite substantial evidence supporting hypnosis, its adoption in medical practice remains limited. Dr. Spiegel emphasizes the importance of teaching patients to utilize their brains effectively, advocating for broader access to hypnosis through tools like Reverie.

Hypnosis isn’t losing control; it’s a precise brain state that teaches people to regulate mind and body. Three core mechanisms emerge: reduced activity in the dorsal anterior cingulate cortex, a node tied to attention and threat detection; increased functional connectivity between the dorsolateral prefrontal cortex and the insula, strengthening mind–body control; and inverse connectivity between the prefrontal cortex and the posterior cingulate, dampening the default mode network’s self-referential drift. Together they foster sharper focus, less salience-driven distraction, and better body awareness. Hypnosis is largely self-directed; induction is simple—a quick gaze upward, closed eyes, slow exhale, and a hand floating up. In hypnotizable individuals, this can happen within seconds, illustrating hypnosis as a trainable skill rather than a gimmick. Hypnotizability is a relatively stable trait, measured with a brief induction and scored, with long-term retest correlations indicating limited change. Clinically, hypnosis yields meaningful analgesia and stress reduction. In catheter-based procedures, patients’ pain dropped from about five to one, anxiety from five to zero, and opioid use halved, with faster recovery as a result of reduced distress. Remote self-hypnosis apps yield similar benefits for pain and stress, and can help chronic pain management. Hypnosis also supports smoking cessation, with randomized data showing a subset stopping after one session and many reducing cigarette use substantially; there are vivid patient stories of surprising improvements. Genetics play a role: a COMT variant modulates dopamine metabolism and appears to influence hypnotizability, while imaginative involvement and dissociative histories increase susceptibility. Personality patterns matter too—more organized, rational individuals may be less hypnotizable, whereas creative or imaginative people tend to respond more readily. Techniques range from direct inductions to using self-hypnosis to focus on body relations and breathing. Beyond pain and habit change, hypnotic work raises questions of agency, trauma, and social influence. It can reframe self-narratives, helping survivors process abuse or guilt, though concerns about coercion exist. Breath work complements hypnosis, accelerating relaxation and easing transitions into hypnotic states; cyclic sighing and paced breathing can lower anxiety and support sustained practice. The discussion also situates hypnosis alongside other altered states that suppress the default mode network, including meditation and psychedelics, highlighting a continuum of tools for attention, emotion regulation, and pain relief. In sum, hypnosis engages robust brain networks to reduce arousal, reshape perception, and expand personal agency when guided with care and integrated with other modalities.

In this episode of Mind Pump, hosts discuss Brain.fm with CEO Dan Clark, who explains how their sound technology enhances focus, relaxation, and sleep. Users report profound experiences, often feeling as if they worked for hours when only 30 minutes have passed. Brain.fm has grown significantly, with over four million users and a conversion rate three times higher than typical apps after users try it for an hour. The music is designed to induce specific brain states by modulating sound patterns that affect blood flow and brain waves, making it effective for various cognitive tasks. Clark shares that Brain.fm is particularly beneficial for individuals with ADHD, anxiety, and other attentional disorders. The company is exploring potential applications in schools and medical settings, including studies on anesthesia recovery. Users have reported improved focus and sleep, with many finding it more effective than traditional medications. The conversation also touches on the impact of morning routines on productivity and the potential for future studies involving wearables to personalize the experience further. Brain.fm is currently expanding its marketing efforts, aiming to reach more people with its unique sound technology.

Hypnosis is a state of focused attention that can significantly alter how the brain processes pain, sleep, and stress. David Spiegel discusses how hypnosis can be a powerful tool for pain management, emphasizing that pain is largely a brain interpretation of bodily signals. Users of the Reverie app report a 30% reduction in pain within 15 minutes of practicing self-hypnosis. In terms of sleep, hypnosis helps individuals dissociate physical tension from mental arousal, allowing for relaxation and improved sleep quality. Users often find it effective, with one user expressing that it was the first time in 15 years she had a good night's sleep. Stress management is another area where hypnosis can be beneficial, as it helps individuals control their physiological responses to stressors rather than being overwhelmed by them. Spiegel highlights the cognitive flexibility that comes with hypnosis, allowing individuals to view situations from different perspectives. This flexibility can be particularly useful in managing pain, as it enables people to reinterpret sensations. He cites a study published in The Lancet, where patients undergoing invasive procedures experienced significantly less pain and anxiety when using self-hypnosis compared to standard care, leading to faster procedure completion and reduced opioid use. The conversation also touches on the historical context of hypnosis, tracing its roots back to early practitioners like Franz Anton Mesmer. Spiegel notes that hypnosis has often been misunderstood, facing skepticism and prejudice, particularly regarding psychological issues. He argues that psychological pain is just as real as physical pain and can be effectively managed through hypnosis. Spiegel shares personal anecdotes, including his own experiences with hypnosis for pain management after surgery and his father's influence in the field. He emphasizes the importance of teaching individuals to collaborate with their healthcare providers and take control of their health through self-hypnosis. The discussion concludes with Spiegel encouraging people to explore hypnosis, particularly through the Reverie app, which offers accessible self-hypnosis tools. He stresses that hypnosis can be a valuable addition to traditional medical approaches, helping individuals manage pain, stress, and sleep issues effectively.

James Nestor discusses how the human habit of dysfunctional breathing underpins a wide range of health issues, emphasizing that breathing is a continuous, energy-driving process rather than just a response to food and drink. He argues that most people breathe suboptimally due to anatomical and lifestyle changes that have emerged with industrialization, particularly noting smaller mouths and narrower airways that push people toward mouth breathing. The conversation explores how soft, processed foods and reduced chewing in early childhood contribute to facial and dental development that limits airway space, linking these structural changes to snoring, sleep apnea, and impaired nasal breathing. The discussion then shifts to the physiology of breathing, explaining that mouth breathing tends to shallowly pull air into the chest, reduces CO2 tolerance, and disrupts the balance of oxygen delivery to tissues. Nestor explains CO2’s essential role in releasing oxygen from hemoglobin and maintaining blood pH, warning that chronic over-breathing can place the body under sustained low-grade stress and blur the line between rest and stress. The host and guest examine the nose as the preferred conduit for air, noting benefits such as nitric oxide production, improved filtration, and better sleep quality when nasal breathing is habitual. They cover practical strategies to retrain breathing, including daytime nasal breathing, diaphragmatic technique, and gradual use of sleep tape, while acknowledging that structural obstructions may require medical or dental interventions such as deviated septum corrections or orthodontic considerations. Throughout, the pair reflect on the variability of individual circumstances, offering a spectrum of approaches rather than universal prescriptions. The episode also delves into broader implications for chronic disease, sleep, and mental health, highlighting the potential of breathing retraining to improve conditions like asthma, hypertension, and anxiety by stabilizing the autonomic nervous system and reducing nocturnal arousal. Personal stories from the guests, expert references, and a focus on accessible, low-cost practices underscore the theme that empowering everyday breathwork can meaningfully extend healthspan, provided foundational, consistent habits are established.

In this episode of the Tim Ferriss Show, Tim interviews Dr. Adam Gazzaley, a prominent neuroscientist and director of the Gazzaley Lab at UC San Francisco. Gazzaley discusses his unique research approach, which combines various neuroscience tools like fMRI, EEG, and transcranial stimulation to explore cognitive enhancement and neuroplasticity through custom-designed video games. One of his notable projects, Neuroracer, aimed to improve cognitive control in older adults through a specially designed video game. The study revealed that participants who played the game for just one month showed significant improvements in multitasking abilities, which persisted for six months after training. Gazzaley emphasizes the importance of understanding the mechanisms behind these changes and the potential for video games to serve as therapeutic tools. Gazzaley's lab also focuses on how cognitive training can be enhanced through multimodal approaches, including the combination of video games with neurofeedback, electrical stimulation, and even performance-enhancing drugs. He highlights the need for rigorous scientific validation of these methods, distinguishing between simply being "based on science" and being "validated by scientific methodology." The conversation touches on the challenges of bridging the gap between basic neuroscience research and practical applications in cognitive enhancement. Gazzaley expresses a desire to create engaging, effective interventions that can be prescribed to improve cognitive function in both healthy individuals and those with cognitive impairments. Gazzaley also shares insights into his personal journey, including his early inspirations from Carl Sagan's *Cosmos* and his passion for photography, which he sees as a parallel exploration of nature akin to scientific inquiry. He discusses his upcoming project, "Neuroman," where he will personally engage with three of his lab's games to assess their effects on his cognitive and physiological metrics over two months. The episode concludes with Gazzaley's reflections on the importance of fearlessness in pursuing innovative research and the potential for future advancements in neuroscience and cognitive enhancement through technology. He encourages listeners to explore the work of his lab through their website, gazzaly.com.

Chemotherapy poses significant challenges for brain cancer patients due to the need for high doses to penetrate the blood-brain barrier. A new technology, developed by Dr. Brian Mogan and his team, can pass through this barrier and has potential applications for addiction treatment, particularly for veterans struggling with sleep and substance use issues. The technology, called Happy, uses recorded frequencies that mimic compounds like caffeine, THC, and melatonin, allowing users to experience effects without ingesting the substances. Dr. Mogan, a biomedical engineer with a PhD in brain-computer interfaces, explains that the technology originated from military research aimed at detecting small magnetic fields. The team discovered they could record the electromagnetic signatures of various compounds and then replay these signals to influence the body’s response as if the actual compounds were present. This approach has shown promise in treating conditions like anxiety and sleep disorders, with users reporting improved sleep quality. Happy's applications extend to performance enhancement for athletes, providing a way to manage anxiety and focus during competitions. The technology is being integrated into treatment plans for veterans, offering a non-invasive tool for managing addiction and mental health challenges. Future developments may include broader applications in medical settings, allowing healthcare providers to prescribe these frequency-based treatments instead of traditional medications. The technology is currently available for consumers, particularly those struggling with sleep issues.

In this podcast, Chris Williamson interviews Jim Poole, who discusses the complexities of human stress, anxiety, and the brain's physiological responses. Poole explains that fear, stress, and anxiety are interconnected and stem from evolutionary brain structures, particularly the central nervous system and the autonomic nervous system. He emphasizes that humans are often not in control of their cravings and responses, as the brain's circuitry prioritizes survival over rational thought. Poole highlights the importance of mindfulness and meditation in reallocating resources to the frontal cortex, which is essential for clear thinking and emotional regulation. He discusses the detrimental effects of modern stressors, including technology and social media, on mental health, leading to heightened anxiety levels. Poole introduces New Calm, a technology designed to balance the autonomic nervous system and alleviate stress without pharmaceuticals. This system utilizes neuroacoustic software to manipulate brainwave frequencies, promoting relaxation and recovery. He notes that stress is a necessary part of life but warns against its excessive impact on well-being. Poole also touches on gender differences in stress responses and coping mechanisms, emphasizing the need for understanding and adaptation. Ultimately, he advocates for a holistic approach to managing stress and achieving balance, encouraging listeners to explore New Calm as a tool for enhancing their mental health and overall quality of life.

In this Huberman Lab Essentials episode, Dr. David Spiegel lays out what hypnosis really is—a state of highly focused attention that can be cultivated to alter perception, bodily responses, and emotional experience. He contrasts clinical hypnosis with stage performances, emphasizing that true therapeutic hypnosis enhances control over mind and body and can be learned through self-hypnosis as well as guided sessions. The conversation delves into the neural mechanisms behind hypnosis, detailing how induction reduces activity in the dorsal anterior cingulate cortex, enhances DLPFC-insula connectivity, and creates inverse coupling between the DLPFC and posterior cingulate cortex, which together foster cognitive flexibility and dissociation from self-referential thinking. Spiegel describes vivid demonstrations, including imagined meals affecting gastric acid via DLPFC-insula pathways, to illustrate how brain states modulate bodily processes. The discussion covers practical applications: reducing stress, aiding sleep, managing pain, and facilitating exposure-based work for phobias and trauma through controlled re-experiencing and reappraisal. They also explore hypnotizability testing, notably the Spiegel hypnotizability assessment and the eye-roll induction, to tailor treatments and guide patients toward self-directed practice. The episode highlights the Revery app as a scalable self-hypnosis tool for pain, stress, focus, insomnia, and healthier habits, while stressing the value of professional supervision for clinical issues and safety considerations for children and OCD. Finally, they reflect on how deliberate, voluntary exposure combined with altered mental state can recalibrate connections within memory and emotion networks, offering a framework for using hypnosis to regain control and improve functioning across mental and physical health domains. topics hypnosis, brain networks, hypnotizability, self-hypnosis, PTSD, phobias, sleep, pain, stress, gamification of therapy, Revery app, clinical practice, eye-roll Spiegel test, dissociation, cognitive flexibility otherTopics clinical vs. stage hypnosis, safety and ethics, pediatric hypnosis, group hypnosis, state-dependent memory, exposure therapy, narrative in therapy, mindfulness vs hypnosis, pharmacology interactions booksMentioned

In this episode of the Huberman Lab Podcast, Andrew Huberman interviews Dr. David Spiegel, a leading expert in hypnosis and its clinical applications. Dr. Spiegel, who is the associate chair of psychiatry and behavioral neurosciences at Stanford, discusses the unique brain state of hypnosis, particularly self-hypnosis, which differs significantly from stage hypnosis. Clinical hypnosis can enhance neuroplasticity, aiding in the treatment of stress, chronic anxiety, chronic pain, and even cancer outcomes. Dr. Spiegel explains that hypnosis involves focused attention and can lead to rapid changes in brain and body states. He introduces a test to assess an individual's hypnotizability, noting that not everyone can be easily hypnotized. His extensive research includes over 480 journal articles and 13 books, establishing him as a foremost authority in the field. The conversation highlights the Reveri app, developed based on clinical studies, which helps users practice self-hypnosis for various issues, including anxiety and sleep improvement. Dr. Spiegel emphasizes the importance of breathwork in conjunction with hypnosis, as it can help regulate mind-body interactions. Dr. Spiegel shares a personal anecdote about his early experiences with hypnosis, including a pivotal moment during a medical rotation where he successfully used hypnosis to help a patient with asthma. He contrasts clinical hypnosis with stage hypnosis, emphasizing that the former is a therapeutic tool that enhances control over one’s mind and body. The discussion also touches on the neurobiological mechanisms of hypnosis, including brain areas involved during hypnotic states. Dr. Spiegel explains how hypnosis can aid in managing pain and stress by altering perceptions and emotional responses. He notes that hypnosis can be particularly effective for phobias, trauma, and grief, allowing individuals to confront and reprocess their experiences. Dr. Spiegel concludes by discussing the importance of facing stress and trauma as a means of building resilience, advocating for a proactive approach to mental health. He encourages listeners to explore self-hypnosis and seek professional guidance when necessary, highlighting the potential for lasting change through these techniques.

The Mind Pump episode features a detailed conversation with Dan from Brain FM about how engineered music can influence brain states and performance. Dan explains that Brain FM uses amplitude modulation and neural entrainment to align brain networks, promoting focus, relaxation, or sleep with precision. The guests discuss how listening to specific rhythmic patterns can alter neurotransmitter activity, blood flow, and functional connectivity in real time, enabling listeners to enter flow states more quickly and sustain deep work. They emphasize that the effects are measured with scientific methods like fMRI and EEG, and that Brain FM has moved from concept to validated practice through collaborations with universities, publishing a Nature-backed paper on improved focus. The dialogue also covers practical usage: tailoring tracks to individual profiles, ADHD sensitivity, and the idea of “effect levels” that scale stimulation for different brains. As the conversation shifts toward broader applications, the hosts explore how wearables, sensors, and even planned workouts could personalize the experience further, enabling smoother transitions between focus, relaxation, and recovery. They also touch on real-world adoption—from astronauts on the International Space Station to students, teachers, and parents seeking alternatives to medication—highlighting Brain FM as a tool that complements traditional approaches rather than replacing them. The discussion closes with reflections on the entrepreneurial journey, the role of science in product development, and the potential to extend Brain FM’s audio-enabled neuromodulation into clinical and everyday settings. The speakers acknowledge limitations, emphasize the importance of controlled studies, and invite listeners to try the program (including a 30-day free trial) while staying curious about ongoing research and future wearables that could make the technology even more accessible and impactful. topicsList1 Neuroscience & Brain Optimization Technology & Innovation Artificial Intelligence & Machine Learning Science & Philosophy Health & Wellness

In this discussion, Jordan Peterson engages with Dr. Daniel M. Higgins and Dr. Robert O. Pihl, reflecting on their 30-year collaboration in psychology and research. They emphasize the importance of understanding personality traits, particularly through the Big Five personality assessment, which can significantly influence hiring decisions and interpersonal dynamics. Peterson highlights that knowing a candidate's extroversion or neuroticism can help interviewers avoid biases, such as conflating confidence with competence. The conversation also touches on the consequences of poor hiring practices, suggesting that it is more brutal to hire inept individuals who negatively impact team performance than to implement rigorous selection methods. They discuss their joint projects, including self-authoring.com, which assists individuals in writing their life narratives, and understandmyself.com, which provides insights into personality traits. These tools aim to help users understand themselves and their relationships better. Peterson recounts his early academic journey, including his unconventional application letter to Dr. Pihl, which led to a fruitful mentorship. They discuss their research on alcoholism and anti-social behavior, exploring the neuropsychological aspects of impulsivity and aggression, particularly in relation to alcohol consumption. The trio reflects on the challenges of conducting research within bureaucratic constraints and the evolution of their work into entrepreneurial ventures. They share insights into the difficulties of selling their psychological assessments to corporations, noting that middle managers often resist innovative ideas due to risk aversion. The conversation shifts to their eventual success in reaching individual users, which allowed them to bypass corporate hurdles and directly impact people's lives through their programs. Peterson and his colleagues express satisfaction with the positive feedback from users of their self-authoring and personality assessment tools, emphasizing the importance of personal agency in the process. They discuss the ethical considerations of pricing their services, arguing that charging for their programs respects users' autonomy and ensures the quality of their offerings. As they conclude, they reflect on the evolution of their business model, the importance of maintaining relationships, and the fulfillment derived from helping others through their psychological interventions. The conversation highlights the intersection of scientific rigor and entrepreneurial spirit in their work, ultimately celebrating their shared vision of providing accessible, effective psychological tools to a broad audience.